|
Yale SPORE in Skin Cancer
|
5P50CA121974-07
|
$2,150,502
|
$258,060
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
2P30CA016359-34
|
$2,531,005
|
$379,651
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-34S1
|
$75,000
|
$11,250
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Wnt5a and TGF-beta in mammary development and cancer
|
5R01CA126942-05
|
$274,339
|
$137,170
|
Serra, Rosa
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Wnt Signaling and Secreted Frizzled-Related Proteins
|
ZIA BC 010251
|
$318,862
|
$63,772
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Wnt Signaling and Prostate Cancer Bone Metastasis
|
5F32CA165689-02
|
$53,942
|
$53,942
|
Simmons, Jessica
|
OHIO STATE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-05S2
|
$37,430
|
$4,866
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-05
|
$1,396,397
|
$181,532
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Whole Genome Amplification and Sequencing of Single Cancer Cells
|
1R33CA174560-01A1
|
$436,919
|
$436,919
|
XIE, XIAOLIANG SUNNEY
|
HARVARD UNIVERSITY
|
|
VHL tumor suppressor gene and the initiation of renal cell carcinoma
|
3R01CA109860-09S1
|
$88,962
|
$88,962
|
HSU, TIEN
|
BOSTON MEDICAL CENTER
|
|
VHL tumor suppressor gene and the initiation of renal cell carcinoma
|
5R01CA109860-09
|
$308,789
|
$308,789
|
HSU, TIEN
|
BOSTON MEDICAL CENTER
|
|
Vesicular stomatitis VSVrp30 selectively destroys human metastatic melanoma
|
5R01CA161048-02
|
$324,515
|
$324,515
|
VAN DEN POL, ANTHONY
|
YALE UNIVERSITY
|
|
Vermont PROSPR Research Center (VPRC)
|
5U54CA163303-03
|
$1,150,391
|
$57,520
|
Sprague, Brian
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VEGF Signaling in Mammary Tumorigenesis
|
5R01CA168464-02
|
$324,596
|
$162,298
|
Mercurio, Arthur
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
VEGF Gene Amplification/Haplotype as Biomarkers for Bevacizumab in Breast Cancer
|
5R01CA155311-03
|
$303,371
|
$303,371
|
Schneider, Bryan
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
5R37CA050286-25
|
$430,440
|
$430,440
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vascular mechanisms regulating breast cancer brain metastasis
|
5R01CA170140-02
|
$335,974
|
$335,974
|
ELICEIRI, BRIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vascular Biology in Cancer
|
ZIA BC 011390
|
$1,345,130
|
$403,539
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Validation of Genomic Targets in Melanoma
|
5R01CA114337-09
|
$323,587
|
$323,587
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Validation of Biomarkers to Distinguish Aggressive from Indolent Prostate Cancer
|
1R21CA176218-01
|
$208,940
|
$104,470
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
5P01CA154291-02
|
$3,054,903
|
$641,530
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-39
|
$4,133,528
|
$702,700
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S1
|
$37,429
|
$6,363
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-39S2
|
$122,414
|
$20,810
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing proteoglycan biology to develop a novel treatment for brain cancers
|
5F31CA168198-02
|
$31,217
|
$7,804
|
Raman, Karthik
|
UNIVERSITY OF UTAH
|
|
Uses of GEM models for Translational Cancer Research
|
5U01CA141508-05
|
$711,971
|
$711,971
|
CHIN, LYNDA
|
UT MD ANDERSON CANCER CTR
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$58,774
|
$41,142
|
Merlino, Glenn
|
CCR (NCI)
|
|
Use of aAPC for Melanoma Adoptive Immunotherapy
|
3R01CA108835-08S1
|
$57,204
|
$57,204
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Use of aAPC for Melanoma Adoptive Immunotherapy
|
5R01CA108835-08
|
$299,653
|
$299,653
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
USE AND OUTCOMES OF INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER
|
5R03CA167454-02
|
$73,027
|
$73,027
|
Tsai, Huei-Ting
|
GEORGETOWN UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S1
|
$12,500
|
$1,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-38S2
|
$12,459
|
$997
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-38
|
$5,870,229
|
$469,618
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-27
|
$1,397,496
|
$600,923
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-09S1
|
$75,000
|
$11,250
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-09S2
|
$112,521
|
$16,878
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-09
|
$1,808,387
|
$271,258
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S1
|
$74,531
|
$8,944
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S2
|
$49,999
|
$6,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
$696,152
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-06
|
$1,463,426
|
$321,954
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
1P30CA177558-01
|
$1,402,503
|
$322,576
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-01S1
|
$75,000
|
$17,250
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S1
|
$25,000
|
$3,750
|
Greenfield, Sheldon
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S2
|
$49,980
|
$7,497
|
Greenfield, Sheldon
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-18
|
$1,168,116
|
$175,217
|
Van Etten, Richard
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Understanding the RhoGDI2 metastasis suppressor gene
|
5R01CA143971-04
|
$331,239
|
$331,239
|
Theodorescu, Dan
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding the origin,initiation,and progression of high-grade serous ovarian
|
1K99CA179137-01
|
$97,200
|
$48,600
|
Kim, Jaeyeon
|
BAYLOR COLLEGE OF MEDICINE
|
|
Understanding the origin and pathogenesis of epithelial ovarian cancer
|
5F32CA159523-03
|
$57,734
|
$57,734
|
Kim, Jaeyeon
|
BAYLOR COLLEGE OF MEDICINE
|
|
Understanding phosphate metabolism in cancer and metastasis
|
1DP2CA186753-01
|
$2,427,500
|
$2,427,500
|
Fiedler, Dorothea
|
PRINCETON UNIVERSITY
|
Total relevant funding to Metastasis for this search: $362,002,333
|